Mumbai, March 15 : Pharma major Ranbaxy Laboratories Friday said it will launch anti-diabetic drug Actos in the US by 2012.
Ranbaxy, majority owned by Japan’s Daiichi Sankyo, said it has settled litigation with the country’s Takeda Pharmaceutical over a generic equivalent version of the medicine and received a non-exclusive royalty free licence for its US [...]